Lv3
258 积分 2025-08-08 加入
A randomized, placebo-controlled phase 3 study of plozasiran in patients with familial chylomicronemia syndrome: PALISADE - 1 year open label extension
17天前
已完结
Efficacy of regorafenib following first-line immune checkpoint inhibitor failure in patients with advanced hepatocellular carcinoma: A multicenter study
4个月前
已完结
A Phase 3 Trial of Inebilizumab in Generalized Myasthenia Gravis
4个月前
已完结
Guidelines for the treatment of psoriasis with biologics and small-molecule drugs in China （2024）
5个月前
已完结
皖公网安备34019202002308
